In this Issue:
Liraglutide and clinical stability of advanced HFREF
Transvenous neurostimulation for central sleep apnoea
Type 2 diabetes and ischaemic/ nonischaemic HF prognosis
ACC/AHA/HFSA guidelines update for HF
NGAL for acute kidney injury during acute HF hospitalisation
Complete left-sided reverse remodelling with CRT
Renal function changes with ACE inhibitor/ARB dosing in HF with CKD
Ethnic differences in association of QRS duration with EF and HF outcomes
Differential response to low-dose dopamine/nesiritide in acute HFP/REF
Lung impedance-guided pre-emptive treatment of chronic HF
Please login below to download this issue (PDF)